Rossari Biotech [ROSSARI] vs Fineotex Chemical [FCL] Detailed Stock Comparison

Rossari Biotech
NSE
Loading...

Fineotex Chemical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rossari Biotech wins in 12 metrics, Fineotex Chemical wins in 8 metrics, with 0 ties. Rossari Biotech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Rossari Biotech | Fineotex Chemical | Better |
---|---|---|---|
P/E Ratio (TTM) | 25.93 | 27.52 | Rossari Biotech |
Price-to-Book Ratio | 2.96 | 3.91 | Rossari Biotech |
Debt-to-Equity Ratio | 18.39 | 0.03 | Fineotex Chemical |
PEG Ratio | -6.56 | -1.85 | Rossari Biotech |
EV/EBITDA | 14.65 | 24.18 | Rossari Biotech |
Profit Margin (TTM) | 6.33% | 19.73% | Fineotex Chemical |
Operating Margin (TTM) | 9.22% | 16.42% | Fineotex Chemical |
EBITDA Margin (TTM) | 9.22% | 16.42% | Fineotex Chemical |
Return on Equity | 11.50% | 14.65% | Fineotex Chemical |
Return on Assets (TTM) | 7.19% | 13.28% | Fineotex Chemical |
Free Cash Flow (TTM) | $-210.69M | $17.57M | Fineotex Chemical |
Dividend Yield | 6.54% | 0.30% | Rossari Biotech |
1-Year Return | -30.64% | -31.49% | Rossari Biotech |
Price-to-Sales Ratio (TTM) | 1.64 | 5.47 | Rossari Biotech |
Enterprise Value | $36.58B | $28.42B | Rossari Biotech |
EV/Revenue Ratio | 1.71 | 5.38 | Rossari Biotech |
Gross Profit Margin (TTM) | 31.70% | 33.53% | Fineotex Chemical |
Revenue per Share (TTM) | $386 | $46 | Rossari Biotech |
Earnings per Share (Diluted) | $24.42 | $9.15 | Rossari Biotech |
Beta (Stock Volatility) | 0.27 | 0.38 | Rossari Biotech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rossari Biotech vs Fineotex Chemical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Rossari Biotech | -1.44% | -0.92% | -11.35% | -3.31% | 1.71% | -20.19% |
Fineotex Chemical | 0.95% | 4.59% | -8.75% | 8.58% | -0.76% | -25.67% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Rossari Biotech | -30.64% | -32.90% | -18.31% | -13.40% | -13.40% | -13.40% |
Fineotex Chemical | -31.49% | -2.65% | 700.78% | 1,089.04% | 980.72% | 980.72% |
Performance & Financial Health Analysis: Rossari Biotech vs Fineotex Chemical
Metric | ROSSARI | FCL |
---|---|---|
Market Information | ||
Market Cap | ₹35.06B | ₹28.88B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 39,841 | 312,015 |
90 Day Avg. Volume | 105,043 | 295,234 |
Last Close | ₹633.25 | ₹255.05 |
52 Week Range | ₹569.00 - ₹972.70 | ₹207.00 - ₹438.95 |
% from 52W High | -34.90% | -41.90% |
All-Time High | ₹1,619.00 (Oct 11, 2021) | ₹458.85 (Feb 19, 2024) |
% from All-Time High | -60.89% | -44.42% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.11% | -0.03% |
Quarterly Earnings Growth | -0.04% | -0.14% |
Financial Health | ||
Profit Margin (TTM) | 0.06% | 0.20% |
Operating Margin (TTM) | 0.09% | 0.16% |
Return on Equity (TTM) | 0.12% | 0.15% |
Debt to Equity (MRQ) | 18.39 | 0.03 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹214.12 | ₹64.46 |
Cash per Share (MRQ) | ₹21.20 | ₹3.66 |
Operating Cash Flow (TTM) | ₹440.09M | ₹1.05B |
Levered Free Cash Flow (TTM) | ₹1.36B | ₹1.08B |
Dividends | ||
Last 12-Month Dividend Yield | 6.54% | 0.30% |
Last 12-Month Dividend | ₹43.78 | ₹0.80 |
Valuation & Enterprise Metrics Analysis: Rossari Biotech vs Fineotex Chemical
Metric | ROSSARI | FCL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 25.93 | 27.52 |
Forward P/E | 18.88 | 19.03 |
PEG Ratio | -6.56 | -1.85 |
Price to Sales (TTM) | 1.64 | 5.47 |
Price to Book (MRQ) | 2.96 | 3.91 |
Market Capitalization | ||
Market Capitalization | ₹35.06B | ₹28.88B |
Enterprise Value | ₹36.58B | ₹28.42B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.71 | 5.38 |
Enterprise to EBITDA | 14.65 | 24.18 |
Risk & Other Metrics | ||
Beta | 0.27 | 0.38 |
Book Value per Share (MRQ) | ₹214.12 | ₹64.46 |
Financial Statements Comparison: Rossari Biotech vs Fineotex Chemical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ROSSARI | FCL |
---|---|---|
Revenue/Sales | ₹5.44B | ₹1.37B |
Cost of Goods Sold | ₹3.71B | ₹911.15M |
Gross Profit | ₹1.72B | ₹459.57M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹501.06M | ₹225.06M |
EBITDA | ₹695.76M | ₹343.40M |
Pre-Tax Income | ₹460.99M | ₹314.94M |
Income Tax | ₹125.03M | ₹64.66M |
Net Income (Profit) | ₹335.96M | ₹250.28M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ROSSARI | FCL |
---|---|---|
Cash & Equivalents | ₹442.02M | ₹292.90M |
Total Current Assets | ₹10.42B | ₹2.61B |
Total Current Liabilities | ₹5.37B | ₹671.02M |
Long-Term Debt | ₹1.22B | N/A |
Total Shareholders Equity | ₹11.85B | ₹7.39B |
Retained Earnings | ₹6.97B | N/A |
Property, Plant & Equipment | ₹0 | ₹1.73B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ROSSARI | FCL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ROSSARI | FCL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 39,841 | 312,015 |
Average Daily Volume (90 Day) | 105,043 | 295,234 |
Shares Outstanding | 55.36M | 114.58M |
Float Shares | 16.51M | 37.74M |
% Held by Insiders | 0.68% | 0.69% |
% Held by Institutions | 0.21% | 0.03% |
Dividend Analysis & Yield Comparison: Rossari Biotech vs Fineotex Chemical
Metric | ROSSARI | FCL |
---|---|---|
Last 12-Month Dividend | ₹43.78 | ₹0.80 |
Last 12-Month Dividend Yield | 6.54% | 0.30% |
3-Year Avg Annual Dividend | ₹14.93 | ₹1.07 |
3-Year Avg Dividend Yield | 1.66% | 0.20% |
3-Year Total Dividends | ₹44.78 | ₹3.20 |
Ex-Dividend Date | Jun 20, 2025 | Feb 18, 2025 |